|
ACE/Angiotension receptors
Citations 21-30 of 225 total displayed.
|
Past content
(since Jun 1999):
|
- Hypertension
Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme Inhibitor
- Xiaowen Su, Liming Lee, Xiaohui Li, Jun Lv, Yonghua Hu, Siyan Zhan, Weihua Cao, Ling Mei, Yong-Ming Tang, Dai Wang, Ronald M. Krauss, Kent D. Taylor, Jerome I. Rotter, and Huiying Yang
Circulation 2007;115:725-732; published online before print as doi:10.1161/CIRCULATIONAHA.106.642058
[Abstract]
[Full text]
- Articles
C-Reactive Protein Causes Downregulation of Vascular Angiotensin Subtype 2 Receptors and Systolic Hypertension in Mice
- Wanpen Vongpatanasin, Gail D. Thomas, Randall Schwartz, Lisa A. Cassis, Sherri Osborne-Lawrence, Lisa Hahner, Linda L. Gibson, Steven Black, David Samols, and Philip W. Shaul
Circulation published February 5, 2007, doi:10.1161/CIRCULATIONAHA.106.664854
[Abstract]
- Articles
Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme Inhibitor
- Xiaowen Su, Liming Lee, Xiaohui Li, Jun Lv, Yonghua Hu, Siyan Zhan, Weihua Cao, Ling Mei, Yong-Ming Tang, Dai Wang, Ronald M. Krauss, Kent D. Taylor, Jerome I. Rotter, and Huiying Yang
Circulation published January 29, 2007, doi:10.1161/CIRCULATIONAHA.106.642058
[Abstract]
- Special Reports
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
- Victor J. Dzau, Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson
Circulation 2006;114:2850-2870, doi:10.1161/CIRCULATIONAHA.106.655688
[Full text]
- Special Reports
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions
- Victor J. Dzau, Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson
Circulation 2006;114:2871-2891, doi:10.1161/CIRCULATIONAHA.106.655761
[Full text]
- Correspondence
Response to Letter Regarding Article, "Angiotensin II Potentiates the Slow Component of Delayed Rectifier K+ Current via the AT1 Receptor in Guinea Pig Atrial Myocytes"
- Dimitar P. Zankov, Mariko Omatsu-Kanbe, Futoshi Toyoda, Wei-Guang Ding, Hiroshi Matsuura, Takahiro Isono, and Minoru Horie
Circulation 2006;114:e566, doi:10.1161/CIRCULATIONAHA.106.640854
[Full text]
- Hypertension
Different Effects of Angiotensin Receptor Blockade on End-Organ Damage in Salt-Dependent and Salt-Independent Hypertension
- Karlene Maitland, LaKeesha Bridges, Wendell P. Davis, Joseph Loscalzo, and Mildred A. Pointer
Circulation 2006;114:905-911; published online before print as doi:10.1161/CIRCULATIONAHA.106.622316
[Abstract]
[Full text]
- Controversies in Cardiovascular Medicine
Angiotensin Receptor Blockers May Increase Risk of Myocardial Infarction: Unraveling the ARB-MI Paradox
- Martin H. Strauss and Alistair S. Hall
Circulation 2006;114:838-854, doi:10.1161/CIRCULATIONAHA.105.594986
[Full text]
- Articles
Different Effects of Angiotensin Receptor Blockade on End-Organ Damage in Salt-Dependent and Salt-Independent Hypertension
- Karlene Maitland, LaKeesha Bridges, Wendell P. Davis, Joseph Loscalzo, and Mildred A. Pointer
Circulation published August 21, 2006, doi:10.1161/CIRCULATIONAHA.106.622316
[Abstract]
- Editorials
Chronic Kidney Disease: Tipping the Scale to the Benefit of Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease
- Peter A. McCullough
Circulation 2006;114:6-7, doi:10.1161/CIRCULATIONAHA.106.636662
[Full text]
|
|
